Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VNDA | AMGN | GILD | VRTX | BIIB |
| Company | Vanda Pharmaceuticals | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 4.94 | 264.63 | 66.25 | 394.72 | 190.72 |
| High | 5.25 | 267.69 | 66.72 | 396.98 | 192.78 |
| Low | 4.93 | 260.68 | 66.16 | 393.00 | 189.44 |
| Last | 5.27 | 266.67 | 66.28 | 394.50 | 192.28 |
| Change | +0.30 | +3.92 | +0.12 | +1.02 | +1.76 |
| % Change | +6.04% | +1.49% | +0.18% | +0.26% | +0.92% |
| Volume | 1,298,858 | 1,115,662 | 3,492,488 | 542,437 | 601,511 |
| 20-Day Average Volume | 5,101,375 | 2,130,266 | 6,089,529 | 890,777 | 1,089,672 |
| Previous Close | 4.97 | 262.75 | 66.16 | 393.48 | 190.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.38 | 272.49 | 69.88 | 405.57 | 204.95 |
| 20-Day Raw Stochastic | 61.70% | 24.24% | 6.65% | 14.45% | 10.04% |
| 20-Day Relative Strength | 62.55% | 42.35% | 29.48% | 38.93% | 30.04% |
| Weighted Alpha | -8.63 | +6.85 | -24.84 | +16.41 | -37.78 |
| Today's Opinion | 56% Buy | 56% Sell | 100% Sell | 8% Buy | 100% Sell |
| Previous Opinion | 56% Buy | 56% Sell | 100% Sell | 8% Buy | 100% Sell |
| Last Month's Opinion | 56% Sell | 8% Sell | 72% Sell | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +26.09% since 04/12/24 | +0.06% since 04/12/24 | -2.41% since 04/12/24 | -0.29% since 04/12/24 | -2.80% since 04/12/24 |
| Low | 3.98 on 04/16/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 5.67 on 04/17/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 402.49 on 04/15/24 | 199.53 on 04/15/24 |
| 1-Month | |||||
| %Chg | +38.16% since 03/19/24 | -1.58% since 03/19/24 | -9.51% since 03/19/24 | -4.77% since 03/19/24 | -11.89% since 03/19/24 |
| Low | 3.71 on 03/20/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 6.03 on 04/03/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 | 221.74 on 03/21/24 |
| 3-Month | |||||
| %Chg | +41.94% since 01/19/24 | -13.12% since 01/19/24 | -23.90% since 01/19/24 | -9.11% since 01/19/24 | -22.93% since 01/19/24 |
| Low | 3.46 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 6.03 on 04/03/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 | 252.17 on 01/22/24 |
| 6-Month | |||||
| %Chg | +20.53% since 10/19/23 | -4.69% since 10/19/23 | -15.31% since 10/19/23 | +8.39% since 10/19/23 | -25.13% since 10/19/23 |
| Low | 3.30 on 11/10/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 6.03 on 04/03/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 285,959 | 140,812,720 | 82,374,304 | 101,698,464 | 27,694,178 |
| Shares Outstanding, K | 57,537 | 535,919 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 192,640,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | 2,510,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 45,270,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | -2,400,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 0.76 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 02/07/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 104.80 | 14.16 | 9.96 | 29.25 | 13.05 |